Tecentriq Hybreza

What is this medication?

Tecentriq Hybreza is a prescription immunotherapy medication used to treat several different types of cancer. It is a combination of two active ingredients, atezolizumab and hyaluronidase-tqjs, and is administered as an injection under the skin. Atezolizumab works as a PD-L1 blocking antibody, which helps the immune system recognize and attack cancer cells more effectively. The hyaluronidase component is an enzyme that increases the permeability of the tissue under the skin, allowing the medicine to be absorbed into the body more efficiently during the subcutaneous injection process.

This medication is approved for use in adults to treat various stages and forms of lung cancer, including non-small cell lung cancer and small cell lung cancer. It is also utilized for treating specific cases of hepatocellular carcinoma, which is a type of liver cancer, as well as melanoma and alveolar soft part sarcoma. Depending on the patient's specific diagnosis and previous treatment history, Tecentriq Hybreza may be used as a single therapy or in combination with other anti-cancer medications and chemotherapy drugs.